[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
February 2, 2000

Alternative Supply of Penicillin G

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(5):596. doi:10.1001/jama.283.5.596

Last June, a major finished product manufacturer of penicillin G (potassium and sodium) in the United States recalled its penicillin G injection products and ceased their distribution. (For details see http://www.fda.gov/medwatch/safety/1999/penici.htm.)

To remedy the resulting shortage, the FDA has identified Biochemie GmbH of Kundl, Austria, as a temporary alternative supplier of penicillin G sodium. The product is labeled and distributed by Geneva Pharmaceuticals Inc in Broomfield, Colo, which is operating under a drug shortage allocation program. Limited supplies are available through regular US wholesale suppliers. While the shortage lasts, physicians are advised to use, where possible, alternative approved therapies instead of penicillin G.

First Page Preview View Large
First page PDF preview
First page PDF preview
×